The American University in Cairo (AUC) and Minapharm Pharmaceuticals announced a new strategic partnership to strengthen ...
The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...
Results from SCOPE to date have enabled Scancell to select Immunobody iSCIB1+, administered needle-free intramuscularly, for further development in patients with selected human leukocyte antigen (HLA) ...
HK Innoen announced on the 26th that it received the highest grade (AA) in the "2025 Second Half ESG Evaluation Results" released by Sustinvest, an ...
We are pleased to welcome Dr. Lee and Dr. Murphy to our Board at an important time for Century as we execute with discipline and focus to bring our most differentiated iPSC-derived cell therapy ...
The global bioreactor market is projected to grow at a compound annual growth rate (CAGR) of around 7%, driven by the rising ...
An update from Scancell Holdings ( ($GB:SCLP) ) is now available. Scancell Holdings has announced positive updated data from its SCOPE Phase 2 ...
Companies who run their early-stage clinical development outside the U.S. would “experience higher fees” according to an FDA ...
China's systematic intellectual property theft campaign poses unprecedented threats to American national security and ...
Aether Biomachines use an AI process to identify novel materials, then build them with biotechnology. They are the first ...
HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics” or the "Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...